Home

Broadfin Capital, LLC

CIK 1511901 · last filed 2022-03-22

Broadfin Capital, LLC is a corporate insider who has filed 26 SEC Form 4 insider transactions across 7 companies since 2014. Across all open-market trades the lifetime net is −$43.4M, making them a net seller over the disclosed history.

"Disclosed insider exposure" sums this person's most-recently-reported share counts across each company they're an insider in, multiplied by the current underlying price. It is not net worth — it misses retail holdings, private investments, real estate, index funds, and any company where the person isn't an SEC-reporting insider. For informational purposes only.

Loading insider history…
Disclosed Exposure

$0

Companies

7

Total Filings

26

Lifetime Open-Market Net

-$43.39M

Holdings By Company

Latest on-record share count from this person's most recent non-derivative Form 4 transaction in each company. Disclosed exposure = shares × current underlying price.
Symbol Role Shares Price Disclosed Exposure Lifetime OM Net Filings Latest Filed
AVADEL PHARMACEUTICALS PLC (AVDL) Delisted Director 3,130,573 $21.64 $67.75M $0 1 2019-08-09
NOVELION THERAPEUTICS INC. (NVLN) Delisted Director — — — $0 2 2018-03-19
Societal CDMO, Inc. (REPH) Delisted 10%+ Owner 2,236,025 $2.09 $4.67M -$1.21M 5 2018-03-15
ARATANA THERAPEUTICS, INC. (PETX) Delisted 10%+ Owner 4,776,834 — — -$15.23M 1 2017-12-01
Corium International, Inc. (CORI) Delisted 10%+ Owner 4,068,626 — — -$12.18M 2 2017-11-03
PROGENICS PHARMACEUTICALS INC (PGNX) Delisted 10%+ Owner 7,147,269 — — -$17.46M 2 2017-02-15
Aegerion Pharmaceuticals, Inc. (AEGR) Delisted 10%+ Owner 4,210,291 — — $2.69M 3 2016-09-12

Recent Filings

26 filings
Insider activity across all companies, newest first. Form 4 rows are post-trade confirmations (buys, sells, grants, exercises). Notice (144) rows are pre-trade notices of intent to sell restricted or control stock under Rule 144 — they may not all execute. Compare adjacent dates to see which notices became actual sales.
Filed Symbol Action Net Shares Net $ Link
2022-03-22 — Mixed −22,765,185 $0
2022-01-31 — Mixed +23,052 $0
2021-11-22 — Buy (P) +300,000 $918.0K
2021-08-10 — Mixed +135,000 $131.8K
2019-12-20 — Mixed — -$27.61M
2019-11-19 — Mixed — -$50.11M
2019-08-15 — Exer (M) +54,369 $0
2019-08-09 AVADEL PHARMACEUTICALS PLC (AVDL) Delisted Grant (A) — $0 EDGAR
2019-07-22 — Disp (D) −21,774,405 $0
2019-04-15 — Mixed −6,000,000 -$30.00M
Showing 1–10 of 26
Page 1 of 3
Form 4 codes: P = open-market purchase · S = open-market sale · A = grant/award · M = option exercise · F = tax withholding at vest · G = bona-fide gift · D = disposition to issuer · J = other (see filing footnote). Only P / S codes carry directional signal.
Notice (144 / 144/A): Form 144 is a notice of intent to sell restricted/control stock under Rule 144, filed before the sale; 144/A is an amendment. Many notices are pre-scheduled under Rule 10b5-1 plans. A Form 4 with code S typically follows within a few days when the planned sale executes; missing follow-up Form 4s suggest the notice was cancelled or modified.